Advanced Flower Capital Inc. (NASDAQ:AFCG) is among the 7 Best Cannabis Stocks to Invest In Now.   Is Advanced Flower Capital Inc. (AFCG) one of the Best Cannabis Stocks to Invest In Now? Advanced Flower Capital Inc. (NASDAQ:AFCG) is among the Best Marijuana Stocks.  TheFly on Jan 05, 2026, stated that, as of January 1, 2026, Advanced Flower Capital Inc. (NASDAQ:AFCG) has successfully converted from a real estate investment trust to a business development company according to the Investment Company Act ...

Core Viewpoint - Innovative Industrial Properties (IIPR) has seen its shares decline over 60% from the peak in Q3 2024, but it offers a high dividend yield of 15.7%, raising questions about its potential recovery by 2026 [1]. Group 1: Positive Factors for Investors - Analysts project a slight revenue growth for Innovative Industrial Properties in 2026, with a consensus estimate of $269.7 million, representing a 1.5% increase from 2025, which is an improvement over recent revenue declines [3]. - The potential rescheduling of marijuana to Schedule III could benefit Innovative Industrial Properties by eliminating Section 280E of the tax code, allowing tenants to deduct standard business expenses, thereby improving their financial positions and ability to pay rents [4]. - The valuation of Innovative Industrial Properties may become more attractive in a favorable regulatory environment, trading at 11.4 times forward earnings, with some discounted cash flow models indicating its intrinsic value is significantly higher than the current share price [5]. Group 2: Risks and Considerations - Despite the potential for share price recovery in 2026, Innovative Industrial Properties remains a risky investment, as even minor underperformance could hinder revenue growth [6]. - Regulatory changes, while potentially beneficial, could also lead to increased competition for Innovative Industrial Properties if the SAFER Act is passed, allowing more banks to offer loans to cannabis operators, which may turn the company into a value trap [7].

Core Viewpoint - The stock market experienced an unexpected decline following the White House's decision to reclassify marijuana as a less dangerous drug [1] Group 1 - The reclassification of marijuana is seen as a significant regulatory change that could impact the cannabis industry [1] - Investors reacted negatively to the news, leading to a drop in stock prices across various sectors [1] - The move may influence future legislation and market dynamics related to cannabis [1]

Legal & Regulatory Landscape - The US cannabis market is facing challenges due to conflicting state laws [1] - Rescheduling cannabis at the federal level is considered overdue [1]

Regulatory Changes & Political Landscape - The DEA is directed to reclassify cannabis from schedule 1 to schedule 3, easing restrictions on medical research, banking, and taxes [1] - A Medicare pilot program will allow some seniors to receive up to $500 per year in hemp-derived CBD products starting in April [2] - Congress passed a ban on all hemp products starting November 2026, including CBD products under the pilot program [2] - The White House will work with Congress to update the statutory definition of final hemp-derived cannabinoid products [3] Industry Dynamics & Lobbying - There has been growing industry engagement and intensified lobbying in Washington [3] - The president shared a medical CBD commercial produced by a longtime friend [4] - Cannabis's influence in DC has seen an uptick year-over-year [6] Strategic Considerations - The executive order is testing a limited medically focused path to reform [4] - The move is appealing to states already moving ahead and keeping tighter controls in place as the 2026 election cycle approaches [4] - The president may see this as appealing to younger and senior voters as the 2026 midterm election process approaches [6]

Cannabis Industry - A new era for cannabis as Trump reclassifies marijuana [1] Business & Finance - TikTok's agreement with American investors [1] - Slower inflation [1] - Trump Media's nuclear fusion deal [1] Other - Mentions of a private defense billionaire [1]

Regulatory Changes - The industry is experiencing a massive shift, potentially the largest in the last 50 years, due to the rescheduling of cannabis [3] - Cannabis is being reclassified from a Schedule 1 drug to a Schedule 3 drug, aligning it with substances like Tylenol with codeine or steroids [2] - This rescheduling is expected to increase access to medical research and attract more investment into the cannabis industry [2] - Companies selling cannabis may benefit from new opportunities to claim basic tax deductions that were previously unavailable [2] Healthcare Access - Dr Oz is introducing a Medicare pilot program to provide eligible seniors with access to cannabis [3] Market Impact - Cannabis stocks are reacting positively to the news [3]

Regulatory Change - The executive order directs the administration to move cannabis into a less restrictive federal category [1] - This action sets in motion a regulatory shift that could alter the legal and commercial landscape for cannabis nationwide [1]

Policy Change - The Trump administration is directed to move cannabis into a less restrictive federal category via executive order [1]

Regulatory Landscape - The U S federal government is considering reclassifying cannabis into a less restrictive federal category [1] Policy Change Impact - President Trump signed an executive order to initiate the change [1]